Country Trust Bank’s Regenxbio RGNX Stock Holding History

Country Trust Bank’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$14.4K	–	633
2025 Q4	$14.4K	Hold	1,000	–	–	﹤0.01%	282
2025 Q3	$9.65K	Hold	1,000	–	–	﹤0.01%	343
2025 Q2	$8.21K	Buy	+1,000	New	+$8.37K	﹤0.01%	326

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Country Trust Bank's RGNX Position: Q1 2026 in Review

Country Trust Bank sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 1,000 shares — an estimated $14.4K sold.

Country Trust Bank first reported a position in RGNX in Q2 2025 and held it in 3 quarters. The position peaked at $14.4K in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

Country Trust Bank reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
Country Trust Bank sold 1,000 Regenxbio shares in Q1 2026, an estimated $14.4K.
Country Trust Bank first reported a position in Regenxbio in Q2 2025 and held it in 3 quarters.
Country Trust Bank's Regenxbio position peaked at $14.4K in Q4 2025.
178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Country Trust Bank's 13F filing for Q1 2026, filed 10 Apr 2026.